<DOC>
	<DOCNO>NCT01337089</DOCNO>
	<brief_summary>This six-month extension study evaluate safety long-term Sativex速 therapy use adjunctive measure patient advance cancer . The study provide continued availability Sativex速 patient complete precede Phase 3 study .</brief_summary>
	<brief_title>Long Term Safety Sativex速 Oromucosal Spray ( Sativex速 ; Nabiximols ) Adjunctive Therapy Patients With Uncontrolled Persistent Chronic Cancer Related Pain</brief_title>
	<detailed_description />
	<criteria>Patient complete parent study within last seven day Willing able give write informed consent Willing able comply study requirement The patient currently use cannabis cannabinoid base medication , parent study IMP , unwilling abstain duration study Any history immediate family history schizophrenia , psychotic illness , severe personality disorder significant psychiatric disorder depression associate underlying condition Any know suspected history substance abuse/dependence disorder ( include opiate abuse/dependence prior diagnosis cancer ) Has poorly control epilepsy recurrent seizure ( i.e . one seizure last year ) Has experience myocardial infarction clinically significant cardiac dysfunction within last 12 month cardiac disorder , opinion investigator would put patient risk clinically significant arrhythmia myocardial infarction Has significantly impair renal function Has significantly impair hepatic function Female patient childbearing potential male patient whose partner childbearing potential , unless willing ensure partner use effective contraception , example , oral contraception , double barrier , intrauterine device , study three month thereafter ( however , male condom use conjunction female condom may prove effective )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>cancer pain</keyword>
	<keyword>opioid therapy</keyword>
	<keyword>inadequate analgesia</keyword>
	<keyword>optimize chronic opioid therapy</keyword>
</DOC>